Temperature changes in vitrectomy

Article

Examining the temperature changes in the vitreous and retina and possible side effects

"Therapeutic hypothermia is being used more and more throughout medicine these days, with many benefits, but also with some possible bad side effects," he continued. "We determined that that we are in fact inducing hypothermia to the retina and vitreous during vitrectomy with unknown (but probably minimal) side effects."

Effect of temperature

"Fortunately," Dr Landers added, "using room temperature infusion fluid during a victrectomy, which induces hypothermia in the retina and vitreous (and probably other structures inside the eye, such as the lens) seems to have minimal side effects."

One of the main concerns and side effects of vitrectomy is cataract. "Many patients undergoing a vitrectomy develop a cataract in their lens sooner than in their nonvitrectomized eye. We don't know the reason for this. It is just possible that it is somehow related to the induced hypothermia... but this is still speculative," he explained.

The study

This prospective study, however, included only six patients and Dr Landers emphasized a need for further research to fully examine what possible effects this change in temperature could have. "Ideally, a larger and longerterm study shoud be performed, possibly even a controlled study that compares the effects of room temperature infusion fluid and warmer, possibly body temperature, infusion fluid to see if the warmed fluid produces fewer cataracts," Dr Landers said. "We are continuing our measurements to obtain larger data sets and we are also testing differing conditions, such as retinal detachments and other situations."

Special contributor

Dr Reece Landers, MD, is a vitreoretinal surgeon at the University of North Carolina, Chapel Hill, North Carolina, USA. He may be reached by Email: maurice_landers@med.unc.edu

Dr Landers has no financial interests in the subject matter.

Reference

1. M.B. Landers 3rd et al., Retina, 2012; 32(1):172–176.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.